lentinan has been researched along with Carcinoma, Ehrlich Tumor in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (85.71) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kong, F; Ning, J; Wu, Z; Yang, G; Yi, J; Yi, Y; Zhang, W | 1 |
Abe, S; Kohno, M; Masuko, Y; Mizono, D; Nakajima, H; Tsubouchi, J; Yamazaki, M; Yoshioka, O | 1 |
Abe, S; Masuko, Y; Mizuno, D; Yoshioka, O | 1 |
Kato, T; Nagatsu, T; Sakakibara, S; Shiio, T | 1 |
Haba, S; Hamaoka, T; Kitagawa, M; Takatsu, K | 1 |
Abe, S; Mizuno, D; Ohkuma, M; Yamazaki, M | 1 |
Egawa, S; Ishibashi, A; Kadowaki, K; Komiyama, K; Umezawa, I | 1 |
7 other study(ies) available for lentinan and Carcinoma, Ehrlich Tumor
Article | Year |
---|---|
Synthesis of beta-(1-->6)-branched beta-(1-->3) glucohexaose and its analogues containing an alpha-(1-->3) linked bond with antitumor activity.
Topics: Allyl Compounds; Animals; Antineoplastic Agents; Carbohydrate Sequence; Carcinoma, Ehrlich Tumor; Cell Line, Tumor; Cyclophosphamide; Glycosides; Lentinan; Male; Mice; Molecular Conformation; Molecular Sequence Data; Oligosaccharides; Stereoisomerism; Structure-Activity Relationship | 2003 |
Combination antitumor therapy with lentinan and bacterial lipopolysaccharide against murine tumors.
Topics: Animals; Carcinoma, Ehrlich Tumor; Escherichia coli; Lentinan; Lipopolysaccharides; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Neoplasm Transplantation; Polysaccharides | 1982 |
Typing of immunomodulators in terms of their effects on the electrophoretic pattern of serum proteins and antitumor combination therapy based on this typing.
Topics: Adjuvants, Immunologic; Animals; Antineoplastic Agents; Blood Proteins; Carcinoma, Ehrlich Tumor; Drug Therapy, Combination; Lentinan; Lipopolysaccharides; Male; Mice; Mice, Inbred Strains; Neoplasm Proteins | 1981 |
Reduction of serum X-prolyl dipeptidyl-aminopeptidase activity in tumour-bearing mice and reversal of reduced enzyme activity by lentinan, an anti-tumour polysaccharide.
Topics: Animals; Carcinoma, Ehrlich Tumor; Dipeptides; Endopeptidases; Female; Lentinan; Leucyl Aminopeptidase; Mice; Neoplasm Transplantation; Polysaccharides; Proline; Sarcoma 180; Sarcoma, Experimental; Transplantation, Homologous | 1979 |
Selective suppression of T-cell activity in tumor-bearing mice and its improvement by lentinan, a potent anti-tumor polysaccharide.
Topics: Animals; Antibodies, Neoplasm; Antigen-Antibody Reactions; Antigens, Bacterial; Antigens, Neoplasm; B-Lymphocytes; Carcinoma, Ehrlich Tumor; Haptens; Hemolytic Plaque Technique; Immunoassay; Immunosuppression Therapy; Lentinan; Mice; Mice, Inbred BALB C; Polysaccharides; Sarcoma, Experimental; T-Lymphocytes; Time Factors | 1976 |
Differentiation of host-mediated antitumor agents from mitotic posons by the antitumor foot-pad reaction in Ehrlich carcinoma-ddY mouse system.
Topics: Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Foot; Immunity; Lentinan; Male; Mice; Mice, Inbred Strains; Mitomycins; Mitosis; Polysaccharides | 1976 |
[Potentiation of combination effect of cisplatin and radiation--application of biological response modifiers].
Topics: Adjuvants, Immunologic; Animals; Carcinoma, Ehrlich Tumor; Cisplatin; Combined Modality Therapy; Humans; Lentinan; Male; Mice; Polysaccharides; Proteoglycans | 1989 |